Analyst Ratings for Monsanto after Its 4Q17 Earnings
Monsanto recently announced its 4Q17 earnings. Its EPS (earnings per share) was $0.05, which was better than a loss of $0.44 in the corresponding quarter a year ago. For fiscal 2017, the company reported EPS of $5.09, which was higher than $2.99 in fiscal 2016. To learn more, be sure to read Monsanto Reports 4Q17 Earnings: Stock Unchanged.
Interested in MON? Don't miss the next report.
Receive e-mail alerts for new research on MON
In October, 17 analysts are covering Monsanto compared to 18 in September. According to Reuters, the current consensus analyst rating for the stock is 2.5 with an overall “hold” recommendation for the next 12 months.
Of the 17 analysts, two have given it a “strong buy” recommendation, and four have given it a “buy,” which is less than five last month. Eleven analysts have recommended a “hold” for the stock, and none of them have recommended a “sell.” That’s similar to Mosaic (MOS) and CF Industries (CF) with most analysts recommending a “hold.”
To find out about Monsanto’s merger update with Bayer, be sure to read Has the Monsanto-Bayer Merger Hit a Snag?
The current consensus price target for Monsanto is $125 as of October 16, 2017. That’s 2.0% higher than the closing price of $122.40 that day.
In the next part, we’ll take a look at FMC (FMC).